What Triggers a Variation Application for a Thai Medical Device License

A registered medical device license in Thailand is not frozen in place, and it is not a document a license holder can quietly update on its own judgment either. Once certain changes occur after registration, the Medical Devices Control Division (MDCD) requires a formal variation application before those changes can be implemented commercially. Knowing exactly where the line falls between a change that needs no filing and one that triggers a full review is one of the more consequential judgment calls a license holder makes over a product's life.

What a Variation Application Actually Is

Under the Medical Device Act B.E. 2551 (2008) and its 2019 amendment (B.E. 2562), a variation, sometimes called an amendment application in Thai regulatory practice, is a formal MDCD submission requesting approval to modify the scope, specifications, or administrative details of an existing device registration. The distinction matters because Thai law does not let a license holder implement material changes unilaterally. Changes past defined thresholds must be reviewed and approved before the modified device can be placed on the Thai market, and the variation application is what starts that review.

Not every post-registration change needs one. MDCD's framework separates major variations, minor variations, and changes that fall outside the requirement entirely, and it is the license holder's responsibility to work out which category applies to a given change and document that assessment internally, whichever way it comes out.

Changes That Trigger a Major Variation

Major variations require a full re-submission reviewed with the same depth as a new registration, and the timeline scales with device class and dossier completeness in roughly the same way a new registration's own timeline does; confirming the current expected review window with MDCD at submission is worth the extra step given how much it varies case by case. Any change to the clinical purpose a device is registered for, including a new indication or a modification to an existing one, is a major trigger, since the registered intended use defines both the device's legal scope of use and the basis for its classification. For active devices, a change to the underlying technology, moving from analog to digital signal processing, switching energy source from electrical to ultrasonic, or altering the operating principle in a way that changes patient or user interaction, also triggers a major variation.

Implantable devices carry their own trigger: any material change in patient contact that could affect biocompatibility, whether a new material, a different material grade, or a surface treatment altering the biological interface, requires major review. Sterile devices are similarly controlled at the barrier level: changes to barrier material, sealing configuration, or packaging geometry that affect sterility assurance require major variation with supporting validation data. And if a change causes the device to be reclassified, whether up or down in risk, the existing registration cannot be amended administratively; the reclassification itself has to move through a major variation, potentially with additional clinical or technical evidence appropriate to the new class.

Changes That Trigger a Minor Variation

Minor variations follow a lighter process with reduced documentation and generally lower fees, covering administrative or presentational changes where the device itself, its performance, and its safety profile stay unchanged. Updates to the Thai-language label, revised translations, updated addresses, or corrected instructional text that does not touch registered indications or contraindications, fall here, though the updated artwork still needs review and approval before use. A manufacturer name or address change at the same physical manufacturing site is minor as well, provided documentary evidence, a revised free sale certificate or facility certificate, confirms manufacturing site continuity.

Changes to the local license holder or authorized representative named in the registration are minor variations, applicable whenever a distributor relationship changes or a foreign manufacturer swaps its in-country partner. Packaging artwork redesigns, color scheme changes, or graphic updates that do not touch labeling claims, indication statements, or required Thai FDA markings are similarly eligible for the lighter minor treatment.

Changes That Need No Variation At All

Some post-registration changes sit entirely outside the variation requirement, though license holders should still document their assessment internally, since MDCD inspectors may ask for the rationale during a post-market inspection. Routine lot release adjustments that stay within the registered device's approved specifications need no filing, since these are batch-level tweaks already covered by the manufacturing range validated at registration.

Software updates are the scenario that catches people out most often. Where an update does not change the device's intended use, does not introduce new algorithms affecting clinical decision outputs, and qualifies as a non-significant change under the manufacturer's own documented change management system, no variation is needed, but a formal change assessment record still has to exist. Any possibility that the update touches intended use or safety and performance characteristics means the change should be escalated for a variation assessment rather than waved through internally. Component replacements can also fall outside the requirement when the replacement is equivalent to the original within the approved design specification, with equivalence backed by objective evidence: material certification, dimensional data, and performance test results where relevant.

Assessing the Change and When to Ask MDCD First

The license holder carries the initial burden of working out whether a proposed change triggers a variation, and this assessment should happen before the change is implemented, referencing MDCD's trigger criteria directly. The output should be a documented change assessment recording the nature of the change, the criteria applied, the conclusion reached, and the supporting rationale, kept on file whether or not a variation was ultimately filed.

Where the assessment is genuinely unclear, MDCD accepts pre-submission inquiries, letting a license holder present the change and get guidance on the correct pathway, or confirmation that no variation is needed at all. This route is worth using when the change is novel, sits at the boundary between major and minor criteria, or involves a higher-risk Class III or Class IV product where an incorrect self-assessment carries the most serious consequences. Fees for variation applications are lower than a fresh registration and scale with both the device class and the significance of the change (major variations cost more than minor ones); since Thai FDA periodically adjusts these schedules and DeeMED has not independently confirmed a specific percentage against the current fee notification, confirming the exact current fee at time of submission is worth the extra step rather than budgeting against an assumed ratio.

Enforcement Treats Undeclared Changes as a Live Compliance Failure

MDCD actively enforces variation requirements through post-market inspection, checking whether the device currently on the Thai market matches its registered specifications. Deviations found during inspection, undeclared changes to labeling, materials, packaging, or device technology, are treated as license violations under the Act, not procedural technicalities. Implementing a change that needed a variation without first getting MDCD approval means placing a non-conforming product on the market under a registration that no longer accurately describes it, and consequences can include product recall, registration suspension, and administrative penalties.

License holders managing multiple registered devices benefit from a standing internal change control procedure that maps every proposed change against MDCD's trigger criteria as a matter of routine, reducing the risk of inadvertent non-compliance and building an audit-ready record for MDCD inspections. When a change is planned as part of a broader product improvement cycle, folding the variation timeline into the project schedule from the outset avoids the operational trap of finishing a change that then cannot reach the Thai market until the variation clears, and for complex or higher-class devices, budgeting at least 180 days between submission and anticipated market availability is a sound planning assumption. DeeMED Consulting helps license holders assess proposed changes against MDCD's criteria and manage the resulting variation or new registration filing from start to approval.